What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.23%Below 5Y avg (1.91%)
Annual Rate
CNY 0.04Paid annual
Payout Ratio
194.8%High
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.02BCNY
447.94M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
200.38x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
560.63MCNY
83.27M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
2.69%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.5540x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-29.98%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
3.02BCNY
447.94M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
3.01BCNY
446.91M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
200.38x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
5.60x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 5.38×.Updated Aug 20, 2026
Price to Book (MRQ)
3.19x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
5.37x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
143.99x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 70.45×.Updated Aug 20, 2026
Gross Margin
42.70%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 33.62%.Updated Aug 20, 2026
Profit Margin
2.69%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
5.92%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
0.16%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
1.47%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
560.63MCNY
83.27M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.94CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-19.70%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
188.46MCNY
27.99M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
42.71MCNY
6.34M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
15.08MCNY
2.24M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-28.10%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
85.28MCNY
12.67M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
68.26MCNY
10.14M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.0357CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
0.23%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
1.91%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
194.81%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 44.64%.Updated Aug 20, 2026
Minority Interest (Equity)
-169.05KCNYFY2025 · Dec 31, 2025
Revenue
582.49MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
378.17MCNYFY2025 · Dec 31, 2025
Gross Profit
204.32MCNYFY2025 · Dec 31, 2025
Operating Income
32.15MCNY
4.77M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
14.87MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-2.01MCNYFY2025 · Dec 31, 2025
Net Income
16.88MCNYFY2025 · Dec 31, 2025
EBIT
14.91MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
52.56MCNYFY2025 · Dec 31, 2025
Research & Development
50.63MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
63.88MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.42MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
744.09KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
42.64KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0929CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0929CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
190.79MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
190.79MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
16.88MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
835.29KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-4.05MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-16.04MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
164.96MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
16.88MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
3.31MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-33.21MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
8.96MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-11.99MCNYFY2025 · Dec 31, 2025
Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025
Purchase of Investments
-650.00KCNYFY2025 · Dec 31, 2025
Sale of Investments
740.00KCNYFY2025 · Dec 31, 2025
Other Investing Activity
-14.71MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-26.61MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00CNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-6.35MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-29.84MCNYFY2025 · Dec 31, 2025
Other Financing Charges
655.08KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-35.54MCNYFY2025 · Dec 31, 2025
Shares Outstanding
196.31MSharesUpdated Aug 20, 2026
Float Shares
65.08MSharesUpdated Aug 20, 2026
% Held by Insiders
68.76%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
5.57%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
224.71MCNY
33.37M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.15CNYUpdated Aug 20, 2026
Total Debt (MRQ)
45.00MCNY
6.68M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0460x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.75x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
5.03CNYUpdated Aug 20, 2026
Total Assets
1.30BCNY
193.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
905.28MCNYFY2025 · Dec 31, 2025
Total Liabilities
332.34MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
398.72MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
0.00CNYFY2025 · Dec 31, 2025
Total Current Liabilities
332.34MCNYFY2025 · Dec 31, 2025
Cash
164.90MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.72MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
170.62MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
30.04MCNYFY2025 · Dec 31, 2025
Accounts Receivable
413.78MCNYFY2025 · Dec 31, 2025
Inventory
160.93MCNYFY2025 · Dec 31, 2025
Accounts Payable
253.43MCNYFY2025 · Dec 31, 2025
Short-term Debt
0.00CNYFY2025 · Dec 31, 2025
Other Current Liabilities
7.62MCNYFY2025 · Dec 31, 2025
Long-term Debt
0.00CNYFY2025 · Dec 31, 2025
Common Stock (Book)
140.22MCNYFY2025 · Dec 31, 2025
Retained Earnings
342.13MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
971.65MCNY
144.31M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
22.20MCNYFY2025 · Dec 31, 2025
52-Week Low
11.59CNYUpdated Aug 20, 2026
52-Week High
24.91CNYUpdated Aug 20, 2026
52-Week Change
-29.98%
vs all stocks
Updated Aug 20, 2026
Beta
0.5540x
vs all stocks
Updated Aug 20, 2026
50-Day MA
14.95CNYUpdated Aug 20, 2026
200-Day MA
17.68CNYUpdated Aug 20, 2026
Avg 10-Day Volume
5.75MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
4.40MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.0800CNYUpdated Aug 20, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 200.38×, higher than 95% of its Scientific & Technical Instruments peers (median 35.69×)Significant